Holen Sie sich die Stockscreener-App
379.79
2.23%
-8.68
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$388.47
Offen:
$386
24-Stunden-Volumen:
3.84M
Relative Volume:
0.47
Marktkapitalisierung:
$344.79B
Einnahmen:
$449.71B
Nettoeinkommen (Verlust:
$12.81B
KGV:
28.68
EPS:
13.2409
Netto-Cashflow:
$19.67B
1W Leistung:
-2.42%
1M Leistung:
+7.01%
6M Leistung:
+15.20%
1J Leistung:
+28.50%
1-Tages-Spanne:
$376.41
$386.52
1-Wochen-Bereich:
$376.41
$393.38
52-Wochen-Spanne:
$234.60
$404.15
Unitedhealth Group Inc Stock (UNH) Company Profile
Firmenname
Unitedhealth Group Inc
Sektor
Branche
Telefon
1-800-328-5979
Adresse
1 HEALTH DRIVE, EDEN PRAIRIE
Compare UNH vs CVS, ELV, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
UNH
Unitedhealth Group Inc
|
379.66 | 352.79B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
90.81 | 118.99B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
388.40 | 85.71B | 200.42B | 5.24B | 6.45B | 23.50 |
CI
Cigna Group
|
280.64 | 75.72B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
304.12 | 36.97B | 137.20B | 1.15B | 1.27B | 9.3439 |
Unitedhealth Group Inc Stock (UNH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-27 | Hochstufung | Erste Group | Hold → Buy |
| 2026-04-22 | Hochstufung | Argus | Hold → Buy |
| 2026-04-07 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2026-04-01 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Buy |
| 2025-07-31 | Herabstufung | Robert W. Baird | Neutral → Underperform |
| 2025-07-30 | Bestätigt | Oppenheimer | Outperform |
| 2025-06-11 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-05-21 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2025-05-19 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-05-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-05-14 | Herabstufung | Raymond James | Strong Buy → Mkt Perform |
| 2025-04-22 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-04-21 | Herabstufung | Argus | Buy → Hold |
| 2025-01-10 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-01-06 | Bestätigt | Truist | Buy |
| 2024-10-17 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-07-17 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2024-06-05 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-04 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-12-18 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2023-10-16 | Hochstufung | UBS | Neutral → Buy |
| 2023-09-06 | Eingeleitet | HSBC Securities | Hold |
| 2023-07-19 | Bestätigt | UBS | Neutral |
| 2023-07-18 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2023-07-17 | Bestätigt | JP Morgan | Overweight |
| 2023-07-17 | Bestätigt | RBC Capital Mkts | Outperform |
| 2023-07-17 | Bestätigt | TD Cowen | Outperform |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-04-05 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-11-21 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-06-01 | Bestätigt | BofA Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-04-21 | Hochstufung | Argus | Hold → Buy |
| 2020-10-19 | Herabstufung | Argus | Buy → Hold |
| 2020-07-01 | Fortgesetzt | SVB Leerink | Outperform |
| 2020-06-05 | Eingeleitet | Goldman | Buy |
| 2020-03-20 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-10-18 | Eingeleitet | Mizuho | Buy |
| 2019-10-10 | Herabstufung | Jefferies | Buy → Hold |
| 2019-09-30 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Hold |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-04-23 | Eingeleitet | UBS | Neutral |
| 2019-04-17 | Bestätigt | BofA/Merrill | Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-09-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-06-11 | Eingeleitet | SunTrust | Buy |
| 2018-03-08 | Eingeleitet | Barclays | Overweight |
| 2018-01-17 | Bestätigt | Citigroup | Buy |
| 2018-01-12 | Bestätigt | Evercore ISI | Outperform |
| 2018-01-03 | Eingeleitet | Goldman | Buy |
| 2017-07-19 | Bestätigt | Mizuho | Buy |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Unitedhealth Group Inc Aktie (UNH) Neueste Nachrichten
Optum Rx Transparency Shift And What It May Mean For UNH Valuation - Yahoo Finance
Berkshire Hathaway Exited UnitedHealth. Here’s What That Means for UNH at $388 - TIKR.com
Barclays Adjusts UnitedHealth Price Target to $429 From $373, Maintains Overweight Rating - marketscreener.com
Is UnitedHealth Group Incorporated (UNH) One of the Best Medical Stocks to Invest in According to Billionaires? - Yahoo Finance
UnitedHealth Group Incorporated stock (US91324P1021): Q1 earnings beat keeps focus on guidance and r - AD HOC NEWS
UnitedHealth Group stock (US91324P1021): Q1 beat keeps investors focused on costs - AD HOC NEWS
What UnitedHealth Group (UNH)'s Upbeat 2026 Outlook and Margin Narrative Means For Shareholders - simplywall.st
UnitedHealth Group Incorporated stock (US91324P1021): earnings beat keeps focus on Medicare costs - AD HOC NEWS
UnitedHealth Group Incorporated stock (US91324P1021): earnings strength meets Medicare cost worries - AD HOC NEWS
UnitedHealth Group (UNH) – Among the 12 Best Dividend Stocks to Invest in According to Hedge Funds - Yahoo Finance
UnitedHealth Group Incorporated stock (US91324P1021): earnings resilience and Medicare pressure in f - AD HOC NEWS
UnitedHealth Group | History, Growth, & Controversies - Britannica
UnitedHealth Group (UNH) Valuation After EPS Guidance Raise And Strong Quarter Fuels Turnaround Expectations - simplywall.st
UnitedHealth Group Stock (UNH) Opinions on Post-Scandal Recovery Efforts - Quiver Quantitative
UnitedHealth Group (UNH) Valuation Check After Recent Share Price Momentum And Undervaluation Narrative - Yahoo Finance
UnitedHealth Group Incorporated stock (US91324P1021): shares rebound after six-session slide - AD HOC NEWS
UnitedHealth Group’s AI Push Tests Cost Control And Competitive Edge - simplywall.st
UnitedHealth snaps six straight sessions of losses (UNH:NYSE) - Seeking Alpha
UnitedHealth Group (UNH) Shares Rebound After UBS Price Target U - GuruFocus
UNH Stock | Unitedhealth Group Inc. Price, Quote, News & Analysis - TipRanks
UnitedHealth Group (UNH) Shares Rebound After Six Sessions of Lo - GuruFocus
UnitedHealth set to snap six straight sessions of losses - MSN
UnitedHealth Group (UNH) – Among the 10 High Quality Stocks to Buy According to Hedge Funds - Yahoo Finance
UNH Stock Quote Price and Forecast - CNN
UnitedHealth Group stock (US91324P1021): Mizuho raises its target after fresh analyst update - AD HOC NEWS
Why UnitedHealth (UNH) Remains a Turnaround Bet Despite Policy and Cost Pressure - Yahoo Finance
Top UnitedHealth Group (UNH) Competitors 2026 - MarketBeat
UnitedHealth Group stock (US91324P1021): earnings miss keeps focus on core health insurance engine - AD HOC NEWS
UnitedHealth Group Incorporated stock (US91324P1021): Shares slide after Medicare and earnings press - AD HOC NEWS
Here's Why UnitedHealth Group (UNH) is a Strong Value Stock - Yahoo Finance
UnitedHealth Group (UNH) Gains as Managed Care Outgrows Economy - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: UnitedHealth (UNH) and Bristol-Myers Squibb (BMY) - The Globe and Mail
UnitedHealth Stock Falls After Berkshire Hathaway Exits Its Entire Multi Million Share Position - TIKR.com
$663.3 Bn Revenue Cycle Management Market Trends and Global Forecasts Report 2026-2035 - GlobeNewswire Inc.
UnitedHealth Group stock (US91324P1021): earnings beat lifts focus - AD HOC NEWS
UnitedHealth (UNH) Faces Bearish Sentiment Amid Light Options Tr - GuruFocus
UNH Maintained by Mizuho -- Price Target Raised to $440 - GuruFocus
UnitedHealth Group Incorporated stock (US91324P1021): Q1 numbers, Medicare pressure and what’s nex - AD HOC NEWS
Buckley Wealth Management, LLC's UnitedHealth Group Inc(UNH) Holding History - GuruFocus
The 50 largest public companies in Minnesota, ranked - Star Tribune
UnitedHealth Group stock (US91324P1021): Q1 earnings beat lifts focus - AD HOC NEWS
UNH Stock Price, Quote & Chart | UNITEDHEALTH GROUP INC (NYSE:UNH) - ChartMill
UnitedHealth Group stock (US91324P1021): Q1 EPS beat and revenue growth draw attention - AD HOC NEWS
Berkshire Exit Puts Spotlight On UnitedHealth Earnings Strength And Regulatory Risks - simplywall.st
Altrius Capital Management Inc's UnitedHealth Group Inc(UNH) Holding History - GuruFocus
Trump’s Portfolio Managers Traded UnitedHealth Ahead of Favorable Medicare Policy Change - Barron's
AMA taps UnitedHealth exec to head its operations - Crain's Chicago Business
UnitedHealth Group Incorporated stock (US91324P1021): earnings beat and guidance focus after recent - AD HOC NEWS
UnitedHealth Under the Microscope After Berkshire Pulls the Plug - The Globe and Mail
UnitedHealth Slips After Berkshire Hathaway Exits Stake - GuruFocus
UnitedHealth Shares Fall After Berkshire Dumps Entire Stake - GuruFocus
Finanzdaten der Unitedhealth Group Inc-Aktie (UNH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):